FRAZIER MANAGEMENT LLC - Q2 2021 holdings

$1.08 Billion is the total value of FRAZIER MANAGEMENT LLC's 34 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 14.3% .

 Value Shares↓ Weighting
ARQT SellARCUTIS BIOTHERAPEUTICS INC$230,170,000
-24.5%
8,434,232
-20.0%
21.23%
-13.2%
PHAT  PHATHOM PHARMACEUTICALS INC$197,258,000
-9.9%
5,827,4150.0%18.19%
+3.6%
PASG  PASSAGE BIO INC$66,322,000
-24.3%
5,009,2190.0%6.12%
-12.9%
MIRM  MIRUM PHARMACEUTICALS INC$61,672,000
-12.8%
3,566,9120.0%5.69%
+0.3%
TBIO SellTRANSLATE BIO INC$57,360,000
+59.4%
2,082,789
-4.6%
5.29%
+83.2%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$55,631,000
+33.8%
2,137,999
+62.8%
5.13%
+53.9%
KRYS SellKRYSTAL BIOTECH INC$53,576,000
-22.3%
787,876
-12.0%
4.94%
-10.7%
PCVX  VAXCYTE INC$51,988,000
+14.0%
2,309,5540.0%4.79%
+31.0%
TARS SellTARSUS PHARMACEUTICALS INC$41,069,000
-33.5%
1,417,157
-26.1%
3.79%
-23.6%
 TRILLIUM THERAPEUTICS INC$30,275,000
-9.4%
3,123,1070.0%2.79%
+4.2%
ANAB  ANAPTYSBIO INC$23,329,000
+20.3%
899,7000.0%2.15%
+38.3%
ALPN  ALPINE IMMUNE SCIENCES INC$23,143,000
-15.1%
2,571,4500.0%2.13%
-2.4%
SNDX SellSYNDAX PHARMACEUTICALS INC$20,400,000
-36.4%
1,188,135
-17.2%
1.88%
-26.9%
STRO  SUTRO BIOPHARMA INC$18,616,000
-18.3%
1,001,4210.0%1.72%
-6.1%
ISEE  IVERIC BIO INC$16,056,000
+2.1%
2,544,5000.0%1.48%
+17.4%
KDNY NewCHINOOK THERAPEUTICS INC$15,532,0001,100,000
+100.0%
1.43%
AUTL NewAUTOLUS THERAPEUTICS PLCspon ads$15,166,0002,283,966
+100.0%
1.40%
FLACU  FRAZIER LIFESCIENCES ACQU COunit 12/09/2025$15,085,000
-1.1%
1,501,0000.0%1.39%
+13.7%
RGNX  REGENXBIO INC$13,673,000
+13.9%
351,9540.0%1.26%
+30.9%
MTEM  MOLECULAR TEMPLATES INC$10,745,000
-38.0%
1,374,0470.0%0.99%
-28.8%
GRTS  GRITSTONE BIO INC$9,412,000
-3.2%
1,030,8780.0%0.87%
+11.3%
EPIX  ESSA PHARMA INC$9,046,000
-1.7%
316,6160.0%0.83%
+13.0%
ACRS SellACLARIS THERAPEUTICS INC$6,510,000
-62.9%
370,733
-46.7%
0.60%
-57.4%
EPZM  EPIZYME INC$6,144,000
-4.6%
739,3690.0%0.57%
+9.7%
APTX SellAPTINYX INC$5,330,000
-44.3%
1,883,244
-41.0%
0.49%
-35.9%
SRRK  SCHOLAR ROCK HLDG CORP$4,508,000
-43.0%
156,0000.0%0.42%
-34.4%
FRLN  FREELINE THERAPEUTICS HLDGSsponsored ads$4,483,000
-33.7%
550,0000.0%0.41%
-23.9%
ALNA  ALLENA PHARMACEUTICALS$4,329,000
-6.5%
3,330,3730.0%0.40%
+7.5%
BLU  BELLUS HEALTH INC NEW$4,030,000
-18.6%
1,296,7430.0%0.37%
-6.3%
SRRA  SIERRA ONCOLOGY INC$3,949,000
+13.0%
202,8030.0%0.36%
+30.0%
AVDL  AVADEL PHARMACEUTICALS PLCsponsored adr$3,891,000
-25.5%
578,1040.0%0.36%
-14.3%
IMVT SellIMMUNOVANT INC$2,685,000
-67.0%
254,000
-50.0%
0.25%
-62.1%
GRTX  GALERA THERAPEUTICS INC$2,369,000
+11.4%
241,0000.0%0.22%
+27.5%
 NABRIVA THERAPEUTICS PLC$575,000
-18.7%
425,6500.0%0.05%
-7.0%
ITRM ExitITERUM THERAPEUTICS PLC$0-1,538,316
-100.0%
-0.17%
CRDF ExitCARDIFF ONCOLOGY INC$0-293,500
-100.0%
-0.22%
ADVM ExitADVERUM BIOTECHNOLOGIES INC$0-1,437,028
-100.0%
-1.14%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-11
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COLLEGIUM PHARMACEUTICAL INC21Q4 202037.0%
ANAPTYSBIO INC20Q4 202163.7%
CIDARA THERAPEUTICS INC20Q3 202017.2%
IOVANCE BIOTHERAPEUTICS INC19Q4 202113.7%
ALLENA PHARMACEUTICALS INC18Q1 202211.9%
ALPINE IMMUNE SCIENCES INC18Q4 20219.1%
APTINYX INC15Q4 202116.9%
KRYSTAL BIOTECH INC14Q4 20219.7%
GRITSTONE ONCOLOGY INC14Q4 20218.2%
SIERRA ONCOLOGY INC12Q4 20196.6%

View FRAZIER MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-14
13F-HR2022-08-10
13F-HR2022-05-13
13F-HR2022-02-08
13F-HR2021-11-12
13F-HR2021-08-11
13F-HR2021-05-12
13F-HR2021-02-11
13F-HR2020-11-12
13F-HR2020-08-04

View FRAZIER MANAGEMENT LLC's complete filings history.

Compare quarters

Export FRAZIER MANAGEMENT LLC's holdings